Literature DB >> 1639616

Reciprocal corneal transplantation fails to correct mucopolysaccharidosis VI corneal storage.

G Aguirre1, I Raber, M Yanoff, M Haskins.   

Abstract

This report contains the results of studies designed to evaluate corneal clearing in mucopolysaccharidosis VI (MPS VI)-affected cats. Corneal buttons from affected cats were transplanted into normal cat corneas and, as controls, normal-to-normal and normal-to-affected transplants also were done. No clearing of the MPS VI graft or host beds occurred, nor was there any clouding of the normal donor or recipient corneal tissues. This assessment was made by serial clinical examinations over a 14-30 mo period and by light and electron microscopic examination of the corneal tissues at the end of the study. Lack of corneal clearing under conditions that would maximize such a process in this animal model indicates that corneal clearing is not an appropriate index for measuring the success of systemic therapy in MPS VI.

Entities:  

Mesh:

Year:  1992        PMID: 1639616

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.

Authors:  A C Crawley; K H Niedzielski; E L Isaac; R C Davey; S Byers; J J Hopwood
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up.

Authors:  E Herskhovitz; E Young; J Rainer; C M Hall; V Lidchi; K Chong; A Vellodi
Journal:  J Inherit Metab Dis       Date:  1999-02       Impact factor: 4.982

3.  Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation.

Authors:  M S Sands; C Vogler; A Torrey; B Levy; B Gwynn; J Grubb; W S Sly; E H Birkenmeier
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

4.  Does enzyme replacement therapy influence the ocular changes in type VI mucopolysaccharidosis?

Authors:  Susanne Pitz; Olufunmilola Ogun; Laila Arash; Elke Miebach; Michael Beck
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-22       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.